ImmunoGen (Nasdaq: IMGN) closed at $8.06. ImmunoGen most advanced compound, trastuzumab-DM1 (breast cancer ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE